Literature DB >> 6173444

A whole-blood technique for testing production of human interferon by leukocytes.

H Kirchner, C Kleinicke, W Digel.   

Abstract

Interferon production was studied in mixtures of whole blood of healthy adults with tissue culture medium. There was no need to supplement the system with additional foreign serum and even the autologous serum and even the autologous serum could be removed by washing in serum-free medium with-out impairment of interferon production. Heparinized blood samples could be stored in the refrigerator overnight before performing the assay. In this test, production of interferon gamma was observed in response to phytohemagglutinin, concanavalin A, pokeweed mitogen, staphylococcal enterotoxin A, and to OKT-3, a monoclonal anti-T cell antibody. Production of interferon alpha was observed when viruses were used as inducers. Our experiments show that in the whole-blood assay the responses to several inducers of different types of interferons may be readily monitored under serum-free conditions. We believe that this test will be of value for testing large numbers of normal individuals (for investigations of the genetics of interferon production) or of patients with a variety of diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6173444     DOI: 10.1016/0022-1759(82)90195-8

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

1.  A preliminary study of the effects of repeated massage on hypothalamic-pituitary-adrenal and immune function in healthy individuals: a study of mechanisms of action and dosage.

Authors:  Mark H Rapaport; Pamela Schettler; Catherine Bresee
Journal:  J Altern Complement Med       Date:  2012-07-09       Impact factor: 2.579

2.  Modulation of granulocyte oxidative response by recombinant interferon alpha 2 and gamma.

Authors:  A Kapp; H Kirchner; H Wokalek; E Schöpf
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

3.  Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens.

Authors:  J M Brand; P Neustock; A Kruse; L Alvarez-Ossorio; A Schnabel; H Kirchner
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

4.  Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls.

Authors:  M T Collins; G Lisby; C Moser; D Chicks; S Christensen; M Reichelderfer; N Høiby; B A Harms; O O Thomsen; U Skibsted; V Binder
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

Authors:  E M Martínez-Cáceres; M A Barrau; L Brieva; C Espejo; N Barberà; X Montalban
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

6.  Increased IL-10 production by stimulated whole blood cultures in primary IgA nephropathy.

Authors:  J W De Fijter; M R Daha; W E Schroeijers; L A van Es; C Van Kooten
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

7.  Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia.

Authors:  U K Kolling; F Hansen; J Braun; L Rink; H A Katus; K Dalhoff
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

8.  Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis.

Authors:  J Vilcek; A Klion; D Henriksen-DeStefano; A Zemtsov; D M Davidson; M Davidson; A E Friedman-Kien; J Le
Journal:  J Clin Immunol       Date:  1986-03       Impact factor: 8.317

9.  Production of interferon and lymphoproliferative response in whole blood cultures derived from patients with atopic dermatitis.

Authors:  A Kapp; R Gillitzer; H Kirchner; E Schöpf
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

10.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.